Cardiology

Few people with heart failure may get a critical type of care

Medicare coverage for cardiac rehabilitation for some people with heart failure was expanded almost a decade ago, and medical guidelines recommend it. Yet those who could benefit often don't get it, a new study finds.

Medications

Q&A: Experts discuss pros, cons of new Alzheimer's drug

Patient care teams are preparing to offer lecanemab, a new Alzheimer's disease treatment expected to soon receive approval from the U.S. Food and Drug Administration (FDA), to patients in the coming months.

page 8 from 40